A digital twin technology to revolutionize stent-graft selection for precise, patient-specific surgeries
Achieve perfect procedural outcomes every time with confidence
TEVAR-Twin Solution
TEVAR-Twin offers AI/ML-enabled precision medicine, user-friendly software needing only pre-surgical patient CT images. It relies on clinically-validated high-fidelity numerical models to guide surgeons in selecting the “best-fit” stent-graft.
PATIENTS
51
digital twins with research collaboration with Politecnico di Milano
Clinical centres
34
in 11 countries across Europe and North America
Patents
2
and >10 scientific publications on peer-reviewed journals
About AllStent
The AllStent is a MedTech company founded by a team with >50-years experience in numerical modelling through global collaborations with leading vascular surgeons and stent-graft manufacturers. Additionally, we have deep expertise in MedTech start-up financing and commercialization, and are pursuing US and EU regulatory clearances.
Testimonials
Santi Trimarchi, MD
Policlinico di Milano Hospital (Italy)
The presence kinking prediction and post-operative validation made the results of the simulation very credible.
Javiér Rio Gomez, MD
Hospital General Universitario Gergorio Maranon (Spain)
Before simulations, I didn’t expect big changes in stent configuration changing landing zone. It's interesting to realize how landing zone affects on stent expansion
Theodoros Kratimenos, MD
Evangelismos General Hospital of Athens (Greece)
Preoperative simulation can be a game changer as predicts possible device misalignment
and the best strategy for the patient-specific case!
our partners
Latest News
April 10th, 2025 |
In the press: "Corriere della Sera"
Surgical stents, plant-based sushi, and instant diagnostics: the startups of Berkeley SkyDeck Europe in search of investors
April 2nd, 2025 |
AllStent Joins Berkeley SkyDeck Europe, Secures €145k Investment
"We are excited to join SkyDeck and leverage its world-class ecosystem to accelerate our growth and impact in TEVAR surgery", Paul Chipperton, CEO
October 28th, 2024 |
AllStent Accepted into the ECHO 2025 Experiential Training Program to compete for C$250,000 prize
ECHO Entrepreneurship, Canada, is training the next generation of innovators in all aspects of advancing cardiovascular care. The program aims to bridge the translational gap for cardiovascular innovations.